Ruth Tal-Singer joins GAAPP as Chief Scientific Officer
The Global Allergy & Airways Patient Platform (GAAPP) is pleased to announce Ruth Tal-Singer, Ph.D., is joining as Chief Scientific Officer.
The Global Allergy & Airways Patient Platform (GAAPP) is pleased to announce Ruth Tal-Singer, Ph.D., is joining as Chief Scientific Officer.
The Severe Asthma Index has been in development for over a year, engaging the global severe asthma community and measuring over 600 quantitative and qualitative data references against 28 indicators to create five key measurement categories.
“How Fit Are Your Lungs?” campaign puts the lungs front and center and explains the importance of lung function testing. In addition, anyone who wants to can do free spirometry on-site.
Are you or a loved one currently dealing with a health condition that has limited treatment options? If so, you may be interested in participating in a clinical research survey that could help shape the future of healthcare.
For 2023 #WorldAsthmaDay, we continue and expand upon our previous campaign, Asthma Care Access: The Voice of the Uncared.
GAAPP and the Canadian Association of Chronic Urticaria conducted a survey of healthcare providers, researchers, and industry partners who were Allergists, Immunologists, Clinical Specialist Nurses, Professors, and Global Medical Leaders.
Zavod Atopika launched the first national media campaign on atopic dermatitis…
Creating a Patient Organization You want to incorporate a Patient…
COPD Patient Charter Implemented in Austria Our member, the Austrian Lungenunion,…
Speak up for COPD We want you to lend your…